PLAY PODCASTS
Fatty Liver Is Not a Liver Problem — It’s a Metabolic Disease
Episode 14

Fatty Liver Is Not a Liver Problem — It’s a Metabolic Disease

Dr. Paika Podcast

January 3, 20266m 52s

Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Fatty liver disease now affects nearly 1 in 3 adults — and most people have no idea they have it. In this short video, Dr. Mohammed Paika explains why fatty liver is not actually a liver problem, but a metabolic and obesity-driven condition rooted in insulin resistance, visceral fat, and modern lifestyle factors.

You’ll learn what fatty liver really is, why obesity and belly fat drive fat buildup in the liver, how this increases your risk for diabetes, heart disease, and liver damage, and most importantly how fatty liver can be reversed with the right metabolic approach.

This video is for anyone who has been told they have fatty liver, elevated liver enzymes, prediabetes, insulin resistance, belly fat, or metabolic syndrome — or for anyone who wants to prevent these conditions before they start.

This is not medical advice. Always discuss your individual situation with your physician.

Subscribe for more science-based videos on obesity, metabolism, fitness, and preventive health.

⚕️ Medical & Educational Disclaimer

The Dr. Paika Podcast and all related content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information shared is not intended as medical advice and should not be used as a substitute for consultation with your personal physician or qualified healthcare professional.

Listening to this podcast does not create a doctor-patient relationship between you and Dr. Paika.

Health, nutrition, exercise, medication, and weight-management topics discussed may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.

Exercise and lifestyle changes carry inherent risks. By choosing to apply any information from this podcast, you accept full responsibility for your health decisions and outcomes.

Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from the use or application of information presented in this podcast.

Topics

Dr Paika PodcastDr Mohammed PaikaDoctor PodcastPhysician PodcastInternal Medicine PodcastHealth Sphere TVDoctor ExplainsDoctor Talks HealthMedical Podcast by DoctorDoctor Education PodcastDoctor Lifestyle PodcastObesity MedicineObesity DoctorObesity TreatmentMetabolic HealthObesity ScienceObesity AwarenessWeight Loss DoctorFat Loss ScienceGLP-1 MedicationsSemaglutide Wegovy OzempicTirzepatide MounjaroBariatric SurgeryNutrition for ObesityBehavioral Weight LossObesity StigmaChronic Disease ManagementDoctor on FitnessExercise ScienceStrength Training MedicineCardio for HealthNASM DoctorLongevity MedicineHealthy AgingMetabolic FitnessDoctor Workout TipsPreventive CardiologyPhysical Activity MedicineHealthy EatingEvidence-Based NutritionProtein for Fat LossPlant-Based DietMediterranean DietLow-Carb High-Protein DietMeal Planning DoctorIntermittent FastingDiet and ObesityHydration Recs NASMDoctor Nutrition AdvicePreventive MedicineInternal Medicine DoctorHospital Medicine StoriesMedical EducationClinical ExperienceDoctor Lessons from 20 YearsMental Health in MedicineDoctor Burnout and MindsetHolistic HealthMedicine and CompassionPhysician MotivationHealthcare ReformPatient EmpowermentJust Human PodcastDoctor StoriesReal Patient StoriesMedicine and HumanitySongs of Unity and Social ChangeEmpathy in HealthcareBreaking Barriers in MedicineHealing Through Storytelling